Detalles de la búsqueda
1.
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.
Diabetes Obes Metab
; 25(11): 3152-3160, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37417375
2.
Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial.
Cardiovasc Diabetol
; 21(1): 49, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379238
3.
Effect of metformin on arginine and dimethylarginines in patients with advanced type 2 diabetes: A post hoc analysis of a randomized trial.
Diabetes Obes Metab
; 24(10): 1983-1988, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789192
4.
Cardiorenal outcomes with dapagliflozin by baseline glucose-lowering agents: Post hoc analyses from DECLARE-TIMI 58.
Diabetes Obes Metab
; 23(1): 29-38, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32844557
5.
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study.
Diabetes Obes Metab
; 21(4): 968-974, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537226
6.
Metformin and ß-cell function in insulin-treated patients with type 2 diabetes: A randomized placebo-controlled 4.3-year trial.
Diabetes Obes Metab
; 20(3): 730-733, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28967181
7.
Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials.
Diabetes Obes Metab
; 25(8): 2413-2418, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37166080
8.
Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.
Diabetes Obes Metab
; 20(1): 219-223, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28681986
9.
Long-term treatment with metformin in type 2 diabetes and vitamin D levels: A post-hoc analysis of a randomized placebo-controlled trial.
Diabetes Obes Metab
; 20(8): 1951-1956, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29667290
10.
Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial.
Diabetes Obes Metab
; 25(10): 3064-3067, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385968
11.
Self-tracking of Physical Activity in People With Type 2 Diabetes: A Randomized Controlled Trial.
Comput Inform Nurs
; 36(7): 340-349, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29742550
12.
Treatment of Painful Diabetic Neuropathy Using Frequency Rhythmic Electro Magnetic Neural Stimulation (FREMS); Effectiveness in Daily Practice.
Diabetes Metab Syndr Obes
; 16: 1383-1391, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37197061
13.
Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial.
Diabetes Care
; 46(3): 593-601, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657986
14.
Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trial.
J Diabetes Complications
; 37(4): 108433, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36841085
15.
Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia.
Pharmaceuticals (Basel)
; 15(3)2022 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35337110
16.
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy.
Kidney Int Rep
; 7(1): 36-45, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35005312
17.
Pregnancy Outcomes: Effects of Metformin (POEM) study: a protocol for a long-term, multicentre, open-label, randomised controlled trial in gestational diabetes mellitus.
BMJ Open
; 12(3): e056282, 2022 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35354633
18.
Metformin and N-terminal pro B-type natriuretic peptide in type 2 diabetes patients, a post-hoc analysis of a randomized controlled trial.
PLoS One
; 16(4): e0247939, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33830998
19.
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.
Lancet Diabetes Endocrinol
; 8(4): 301-312, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32135136
20.
Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3year trial.
J Diabetes Complications
; 32(2): 171-178, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174300